In 2011, TLL published 59 papers in peer-reviewed journals and made five
discoveries including the specific Enterovirus 711
monoclonal antibodies
which can be further developed as potential therapeutics.
TLL continues to nurture scientific talent from around the world and provides
opportunities for them to become leaders in their fields.